Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension

Trial Profile

Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2015

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Jun 2012 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 18 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top